| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics, Local | 37 | 2024 | 1004 | 5.130 |
Why?
|
| Anesthesia, Conduction | 15 | 2024 | 263 | 3.710 |
Why?
|
| Nerve Block | 17 | 2024 | 716 | 3.150 |
Why?
|
| Pain, Postoperative | 22 | 2024 | 1765 | 3.020 |
Why?
|
| Lidocaine | 14 | 2024 | 546 | 2.980 |
Why?
|
| Diabetic Neuropathies | 8 | 2018 | 410 | 2.530 |
Why?
|
| Anesthesia, Epidural | 7 | 2021 | 232 | 2.470 |
Why?
|
| Analgesia | 8 | 2022 | 460 | 2.030 |
Why?
|
| Anesthesia, Spinal | 6 | 2023 | 282 | 2.010 |
Why?
|
| Analgesia, Epidural | 10 | 2019 | 332 | 1.880 |
Why?
|
| Sciatic Nerve | 11 | 2024 | 628 | 1.550 |
Why?
|
| Amides | 5 | 2016 | 452 | 1.360 |
Why?
|
| Anesthesiology | 7 | 2022 | 1137 | 1.290 |
Why?
|
| Perioperative Period | 4 | 2020 | 252 | 1.230 |
Why?
|
| Anesthesia | 7 | 2022 | 1596 | 1.220 |
Why?
|
| Norepinephrine | 2 | 2021 | 900 | 1.200 |
Why?
|
| Phantom Limb | 3 | 2023 | 106 | 1.180 |
Why?
|
| Ganglia, Spinal | 10 | 2012 | 530 | 1.160 |
Why?
|
| Anesthesia, Obstetrical | 4 | 2017 | 235 | 1.120 |
Why?
|
| Peripheral Nerves | 7 | 2024 | 492 | 1.040 |
Why?
|
| Anesthesia, Local | 4 | 2023 | 279 | 1.020 |
Why?
|
| Bupivacaine | 10 | 2019 | 413 | 0.970 |
Why?
|
| Analgesics | 11 | 2024 | 1072 | 0.850 |
Why?
|
| Ligamentum Flavum | 4 | 2016 | 20 | 0.840 |
Why?
|
| Amputees | 1 | 2023 | 100 | 0.810 |
Why?
|
| Analgesics, Opioid | 11 | 2024 | 3837 | 0.800 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2012 | 692 | 0.800 |
Why?
|
| Colorectal Surgery | 1 | 2024 | 125 | 0.780 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2016 | 302 | 0.740 |
Why?
|
| Abscess | 3 | 2021 | 606 | 0.730 |
Why?
|
| Perioperative Care | 4 | 2024 | 1045 | 0.710 |
Why?
|
| Hematoma, Epidural, Spinal | 2 | 2018 | 37 | 0.710 |
Why?
|
| Neurons, Afferent | 6 | 2008 | 498 | 0.690 |
Why?
|
| Post-Dural Puncture Headache | 1 | 2021 | 53 | 0.690 |
Why?
|
| Analgesics, Non-Narcotic | 5 | 2019 | 371 | 0.680 |
Why?
|
| Hematoma | 3 | 2021 | 768 | 0.670 |
Why?
|
| Amitriptyline | 4 | 2007 | 112 | 0.660 |
Why?
|
| Analgesia, Obstetrical | 2 | 2018 | 169 | 0.650 |
Why?
|
| Acetaminophen | 6 | 2024 | 556 | 0.640 |
Why?
|
| Meningitis | 1 | 2020 | 219 | 0.630 |
Why?
|
| Atracurium | 5 | 2005 | 51 | 0.620 |
Why?
|
| Pain Measurement | 12 | 2021 | 3585 | 0.600 |
Why?
|
| Injections | 2 | 2018 | 841 | 0.530 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2013 | 716 | 0.520 |
Why?
|
| Pressure | 2 | 2018 | 1172 | 0.500 |
Why?
|
| Thoracic Vertebrae | 3 | 2005 | 614 | 0.500 |
Why?
|
| Exhalation | 3 | 2005 | 185 | 0.480 |
Why?
|
| Risk Management | 1 | 2018 | 558 | 0.480 |
Why?
|
| Laparoscopy | 2 | 2024 | 2055 | 0.460 |
Why?
|
| Anesthesia Recovery Period | 1 | 2015 | 155 | 0.460 |
Why?
|
| Dose-Response Relationship, Drug | 18 | 2018 | 10778 | 0.450 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2021 | 1421 | 0.450 |
Why?
|
| Evidence-Based Medicine | 3 | 2024 | 3709 | 0.440 |
Why?
|
| Intraoperative Complications | 1 | 2020 | 1176 | 0.440 |
Why?
|
| Orthopedics | 1 | 2022 | 906 | 0.440 |
Why?
|
| Serotonin Antagonists | 1 | 2013 | 147 | 0.430 |
Why?
|
| Ondansetron | 1 | 2013 | 95 | 0.420 |
Why?
|
| Orthopedic Procedures | 2 | 2022 | 1280 | 0.420 |
Why?
|
| Membrane Potentials | 5 | 2008 | 1090 | 0.420 |
Why?
|
| Cadaver | 9 | 2024 | 1366 | 0.400 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 1124 | 0.400 |
Why?
|
| Laryngeal Masks | 5 | 2004 | 118 | 0.400 |
Why?
|
| Monitoring, Intraoperative | 1 | 2018 | 950 | 0.390 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2022 | 1405 | 0.380 |
Why?
|
| Data Interpretation, Statistical | 1 | 2021 | 2714 | 0.370 |
Why?
|
| Rats | 18 | 2018 | 23847 | 0.370 |
Why?
|
| DNA Methylation | 3 | 2015 | 4432 | 0.360 |
Why?
|
| Humans | 113 | 2024 | 768887 | 0.350 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 4 | 2005 | 145 | 0.350 |
Why?
|
| Fentanyl | 4 | 2017 | 450 | 0.340 |
Why?
|
| Butadienes | 3 | 2008 | 107 | 0.340 |
Why?
|
| Mass Spectrometry | 8 | 2008 | 2204 | 0.330 |
Why?
|
| Anesthesia, General | 4 | 2017 | 1189 | 0.320 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 1181 | 0.320 |
Why?
|
| Lower Extremity | 4 | 2024 | 1217 | 0.310 |
Why?
|
| Netherlands | 5 | 2020 | 2277 | 0.300 |
Why?
|
| Anesthetics, Inhalation | 6 | 2003 | 573 | 0.300 |
Why?
|
| Axons | 2 | 2007 | 1678 | 0.300 |
Why?
|
| Organic Chemicals | 2 | 2008 | 211 | 0.300 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 1665 | 0.300 |
Why?
|
| Breath Tests | 5 | 2008 | 300 | 0.290 |
Why?
|
| Imidazoles | 3 | 2012 | 1169 | 0.290 |
Why?
|
| Stress, Physiological | 1 | 2015 | 1410 | 0.290 |
Why?
|
| Cervical Vertebrae | 2 | 2004 | 982 | 0.290 |
Why?
|
| Acetonitriles | 2 | 2005 | 55 | 0.280 |
Why?
|
| Neurons | 5 | 2012 | 9524 | 0.280 |
Why?
|
| Pneumonia, Aspiration | 2 | 2004 | 145 | 0.270 |
Why?
|
| Abdomen | 3 | 2019 | 1137 | 0.270 |
Why?
|
| Postoperative Complications | 5 | 2020 | 15889 | 0.270 |
Why?
|
| Pentanes | 2 | 2003 | 5 | 0.270 |
Why?
|
| Hemiterpenes | 2 | 2003 | 18 | 0.270 |
Why?
|
| Hypotension | 1 | 2012 | 888 | 0.260 |
Why?
|
| Isoquinolines | 2 | 2005 | 354 | 0.260 |
Why?
|
| Sulfones | 2 | 2005 | 448 | 0.250 |
Why?
|
| Ketamine | 3 | 2018 | 527 | 0.250 |
Why?
|
| Diclofenac | 2 | 2017 | 69 | 0.250 |
Why?
|
| Neoplasm Metastasis | 2 | 2016 | 4926 | 0.250 |
Why?
|
| Subclavian Vein | 1 | 2005 | 57 | 0.250 |
Why?
|
| Electric Stimulation | 3 | 2017 | 1743 | 0.240 |
Why?
|
| Cesarean Section | 2 | 2012 | 1417 | 0.240 |
Why?
|
| Superior Cervical Ganglion | 1 | 2004 | 33 | 0.240 |
Why?
|
| Acrylates | 2 | 2004 | 75 | 0.240 |
Why?
|
| Hydrofluoric Acid | 1 | 2004 | 13 | 0.240 |
Why?
|
| Epigenesis, Genetic | 2 | 2015 | 3836 | 0.230 |
Why?
|
| Enzyme Inhibitors | 4 | 2012 | 3724 | 0.230 |
Why?
|
| Xerophthalmia | 1 | 2004 | 12 | 0.230 |
Why?
|
| Pantothenic Acid | 1 | 2004 | 17 | 0.230 |
Why?
|
| Neuromuscular Blocking Agents | 2 | 2004 | 132 | 0.230 |
Why?
|
| Adjuvants, Anesthesia | 2 | 2015 | 58 | 0.220 |
Why?
|
| Wound Healing | 1 | 2015 | 2815 | 0.220 |
Why?
|
| Prader-Willi Syndrome | 1 | 2004 | 79 | 0.220 |
Why?
|
| Nitric Oxide Synthase | 3 | 2005 | 911 | 0.220 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2005 | 361 | 0.220 |
Why?
|
| Oral Surgical Procedures | 1 | 2005 | 172 | 0.220 |
Why?
|
| Rats, Zucker | 2 | 2014 | 131 | 0.220 |
Why?
|
| Procaine | 2 | 2014 | 60 | 0.220 |
Why?
|
| Caspases | 3 | 2016 | 881 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 6 | 2019 | 2277 | 0.210 |
Why?
|
| Burns, Chemical | 1 | 2004 | 123 | 0.210 |
Why?
|
| Lactones | 1 | 2005 | 316 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 1246 | 0.210 |
Why?
|
| Cell Survival | 5 | 2014 | 5794 | 0.210 |
Why?
|
| Analgesia, Patient-Controlled | 3 | 2017 | 117 | 0.210 |
Why?
|
| Cellulose | 1 | 2003 | 117 | 0.210 |
Why?
|
| Halothane | 1 | 2003 | 200 | 0.210 |
Why?
|
| Thigh | 1 | 2024 | 239 | 0.210 |
Why?
|
| Dwarfism | 1 | 2003 | 137 | 0.200 |
Why?
|
| Limb Deformities, Congenital | 1 | 2003 | 136 | 0.200 |
Why?
|
| Musculoskeletal Diseases | 2 | 2019 | 601 | 0.200 |
Why?
|
| Biomedical Research | 1 | 2018 | 3463 | 0.200 |
Why?
|
| Radial Artery | 1 | 2004 | 188 | 0.200 |
Why?
|
| Upper Extremity | 2 | 2024 | 683 | 0.200 |
Why?
|
| Inflammation | 4 | 2015 | 10869 | 0.190 |
Why?
|
| Delirium | 1 | 2013 | 1696 | 0.190 |
Why?
|
| Pyridines | 3 | 2012 | 2896 | 0.190 |
Why?
|
| Wounds, Penetrating | 1 | 2004 | 316 | 0.190 |
Why?
|
| Action Potentials | 4 | 2015 | 1838 | 0.190 |
Why?
|
| Electrocardiography | 1 | 2014 | 6413 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2012 | 8200 | 0.180 |
Why?
|
| Animals | 24 | 2018 | 169408 | 0.180 |
Why?
|
| Female | 47 | 2024 | 397464 | 0.180 |
Why?
|
| Spinal Nerves | 3 | 2012 | 92 | 0.180 |
Why?
|
| Vitamin A | 1 | 2004 | 611 | 0.180 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2016 | 584 | 0.180 |
Why?
|
| Blood Patch, Epidural | 1 | 2021 | 57 | 0.180 |
Why?
|
| Delphi Technique | 1 | 2024 | 890 | 0.180 |
Why?
|
| Calcium | 3 | 2008 | 5792 | 0.180 |
Why?
|
| Catheterization, Peripheral | 1 | 2004 | 347 | 0.170 |
Why?
|
| Terrorism | 1 | 2003 | 211 | 0.170 |
Why?
|
| Apoptosis | 6 | 2012 | 9528 | 0.170 |
Why?
|
| Critical Care | 2 | 2021 | 2715 | 0.170 |
Why?
|
| Catheterization, Central Venous | 1 | 2005 | 536 | 0.170 |
Why?
|
| Eye | 1 | 2004 | 712 | 0.170 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2015 | 905 | 0.170 |
Why?
|
| Mastectomy | 2 | 2019 | 1850 | 0.170 |
Why?
|
| Wounds and Injuries | 3 | 2017 | 2517 | 0.170 |
Why?
|
| Cognition Disorders | 1 | 2013 | 3985 | 0.170 |
Why?
|
| Prisoners | 1 | 2003 | 316 | 0.160 |
Why?
|
| Methyl Ethers | 5 | 2003 | 196 | 0.160 |
Why?
|
| Needles | 2 | 2015 | 461 | 0.160 |
Why?
|
| Air Pollutants, Occupational | 4 | 2002 | 406 | 0.160 |
Why?
|
| Mass Screening | 3 | 2008 | 5455 | 0.160 |
Why?
|
| Efficiency | 1 | 2022 | 480 | 0.160 |
Why?
|
| Brachial Plexus | 1 | 2021 | 173 | 0.160 |
Why?
|
| Cells, Cultured | 7 | 2012 | 19023 | 0.160 |
Why?
|
| Respiratory Rate | 1 | 2019 | 180 | 0.150 |
Why?
|
| Vital Signs | 1 | 2019 | 144 | 0.150 |
Why?
|
| Arm Injuries | 1 | 2019 | 156 | 0.150 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 21187 | 0.150 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2021 | 538 | 0.150 |
Why?
|
| Leg Injuries | 1 | 2019 | 180 | 0.150 |
Why?
|
| Pregnancy | 7 | 2021 | 30175 | 0.150 |
Why?
|
| Infusions, Intravenous | 2 | 2020 | 2231 | 0.150 |
Why?
|
| Saphenous Vein | 2 | 2021 | 519 | 0.150 |
Why?
|
| Lumbar Vertebrae | 2 | 2005 | 1889 | 0.150 |
Why?
|
| DNA, Neoplasm | 2 | 2014 | 1748 | 0.150 |
Why?
|
| Sodium Channels | 3 | 2008 | 341 | 0.140 |
Why?
|
| Male | 43 | 2024 | 365249 | 0.140 |
Why?
|
| Face | 1 | 2003 | 1031 | 0.140 |
Why?
|
| Terminology as Topic | 1 | 2024 | 1541 | 0.140 |
Why?
|
| Mepivacaine | 1 | 2016 | 8 | 0.140 |
Why?
|
| Time Factors | 11 | 2019 | 40266 | 0.140 |
Why?
|
| Neoplasms | 7 | 2021 | 22390 | 0.140 |
Why?
|
| Enzyme Activation | 3 | 2008 | 3588 | 0.140 |
Why?
|
| Pain | 7 | 2021 | 5100 | 0.140 |
Why?
|
| Sufentanil | 1 | 2016 | 42 | 0.140 |
Why?
|
| Spine | 1 | 2003 | 1141 | 0.130 |
Why?
|
| Treatment Refusal | 1 | 2019 | 432 | 0.130 |
Why?
|
| Intubation, Intratracheal | 5 | 2004 | 1359 | 0.130 |
Why?
|
| Necrosis | 1 | 2020 | 1621 | 0.130 |
Why?
|
| Abnormalities, Multiple | 1 | 2003 | 1423 | 0.130 |
Why?
|
| Operating Rooms | 4 | 2003 | 793 | 0.130 |
Why?
|
| Insurance Claim Review | 1 | 2020 | 746 | 0.130 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2008 | 440 | 0.130 |
Why?
|
| Abdominal Wall | 1 | 2017 | 166 | 0.130 |
Why?
|
| Catastrophization | 1 | 2019 | 352 | 0.120 |
Why?
|
| Consensus | 1 | 2024 | 3214 | 0.120 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2007 | 433 | 0.120 |
Why?
|
| Platelet Count | 1 | 2017 | 787 | 0.120 |
Why?
|
| Lumbosacral Region | 1 | 2016 | 294 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2024 | 10397 | 0.120 |
Why?
|
| Adult | 30 | 2020 | 223818 | 0.120 |
Why?
|
| Risk | 3 | 2017 | 9621 | 0.120 |
Why?
|
| Dexmedetomidine | 1 | 2018 | 320 | 0.110 |
Why?
|
| Middle Aged | 27 | 2020 | 223740 | 0.110 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2013 | 25 | 0.110 |
Why?
|
| Torsades de Pointes | 1 | 2014 | 78 | 0.110 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2013 | 37 | 0.110 |
Why?
|
| Anesthetics, General | 1 | 2015 | 152 | 0.110 |
Why?
|
| Neuromuscular Agents | 1 | 2015 | 148 | 0.110 |
Why?
|
| Renal Dialysis | 1 | 2003 | 1789 | 0.110 |
Why?
|
| Drug Synergism | 2 | 2015 | 1762 | 0.110 |
Why?
|
| Catheterization | 1 | 2019 | 1431 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2004 | 2597 | 0.110 |
Why?
|
| Chi-Square Distribution | 4 | 2019 | 3438 | 0.110 |
Why?
|
| Treatment Failure | 3 | 2022 | 2663 | 0.110 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 732 | 0.110 |
Why?
|
| Neopterin | 2 | 2003 | 58 | 0.110 |
Why?
|
| Aged, 80 and over | 12 | 2020 | 59738 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 310 | 0.100 |
Why?
|
| Azacitidine | 1 | 2014 | 336 | 0.100 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2017 | 472 | 0.100 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 481 | 0.100 |
Why?
|
| Treatment Outcome | 12 | 2021 | 65485 | 0.100 |
Why?
|
| Decompression, Surgical | 1 | 2017 | 610 | 0.100 |
Why?
|
| Magnesium | 1 | 2015 | 816 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 5707 | 0.100 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2012 | 412 | 0.090 |
Why?
|
| Musculoskeletal System | 1 | 2013 | 188 | 0.090 |
Why?
|
| Dexamethasone | 1 | 2019 | 1965 | 0.090 |
Why?
|
| Models, Animal | 2 | 2015 | 2123 | 0.090 |
Why?
|
| Hyperalgesia | 1 | 2015 | 527 | 0.090 |
Why?
|
| Cell Count | 2 | 2012 | 1833 | 0.090 |
Why?
|
| Ultrasonography | 2 | 2021 | 6001 | 0.090 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2010 | 75 | 0.090 |
Why?
|
| Hip Fractures | 1 | 2019 | 996 | 0.090 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2014 | 647 | 0.090 |
Why?
|
| Smoking | 2 | 2005 | 9094 | 0.090 |
Why?
|
| Aged | 18 | 2020 | 171790 | 0.090 |
Why?
|
| Double-Blind Method | 4 | 2017 | 12469 | 0.090 |
Why?
|
| Long QT Syndrome | 1 | 2014 | 472 | 0.090 |
Why?
|
| Cohort Studies | 5 | 2020 | 41800 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 1398 | 0.080 |
Why?
|
| Behavior, Animal | 3 | 2012 | 1879 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 4 | 2021 | 1524 | 0.080 |
Why?
|
| Equipment Failure | 1 | 2012 | 585 | 0.080 |
Why?
|
| Epidural Space | 2 | 2016 | 123 | 0.080 |
Why?
|
| Patient Positioning | 1 | 2012 | 332 | 0.080 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 751 | 0.080 |
Why?
|
| Vascular Resistance | 1 | 2012 | 939 | 0.080 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2011 | 127 | 0.080 |
Why?
|
| Triage | 1 | 2016 | 997 | 0.080 |
Why?
|
| Pattern Recognition, Visual | 1 | 2015 | 826 | 0.080 |
Why?
|
| Cell Size | 2 | 2008 | 626 | 0.080 |
Why?
|
| Forecasting | 1 | 2018 | 2946 | 0.080 |
Why?
|
| Pilot Projects | 4 | 2016 | 8742 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2018 | 23652 | 0.080 |
Why?
|
| Anthracenes | 1 | 2008 | 83 | 0.080 |
Why?
|
| Breast | 1 | 2017 | 1976 | 0.080 |
Why?
|
| Obturator Nerve | 2 | 2023 | 11 | 0.070 |
Why?
|
| Lumbosacral Plexus | 1 | 2008 | 54 | 0.070 |
Why?
|
| Occupational Exposure | 3 | 2003 | 1807 | 0.070 |
Why?
|
| Edetic Acid | 1 | 2008 | 278 | 0.070 |
Why?
|
| Sensory Receptor Cells | 1 | 2012 | 508 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2830 | 0.070 |
Why?
|
| Psoas Muscles | 1 | 2008 | 66 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 1064 | 0.070 |
Why?
|
| Cytoprotection | 1 | 2008 | 200 | 0.070 |
Why?
|
| Retrospective Studies | 7 | 2021 | 81892 | 0.070 |
Why?
|
| Opioid-Related Disorders | 2 | 2019 | 2189 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2005 | 515 | 0.070 |
Why?
|
| Endpoint Determination | 1 | 2010 | 594 | 0.070 |
Why?
|
| Vital Capacity | 1 | 2010 | 997 | 0.070 |
Why?
|
| Data Collection | 3 | 2005 | 3322 | 0.070 |
Why?
|
| Cadmium | 1 | 2008 | 217 | 0.070 |
Why?
|
| Magnesium Sulfate | 1 | 2007 | 73 | 0.070 |
Why?
|
| Visual Cortex | 1 | 2015 | 1112 | 0.070 |
Why?
|
| Emergency Service, Hospital | 4 | 2019 | 7956 | 0.070 |
Why?
|
| Chelating Agents | 1 | 2008 | 385 | 0.070 |
Why?
|
| Skin | 1 | 2020 | 4507 | 0.070 |
Why?
|
| Glucose | 1 | 2018 | 4352 | 0.070 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2006 | 68 | 0.070 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2006 | 93 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 6131 | 0.070 |
Why?
|
| Drug Administration Schedule | 2 | 2012 | 4862 | 0.070 |
Why?
|
| PC12 Cells | 1 | 2006 | 317 | 0.070 |
Why?
|
| Infusions, Parenteral | 2 | 2017 | 397 | 0.070 |
Why?
|
| Single-Blind Method | 1 | 2010 | 1585 | 0.070 |
Why?
|
| Europe | 1 | 2013 | 3441 | 0.070 |
Why?
|
| Enzyme Precursors | 1 | 2006 | 166 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 1904 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2008 | 564 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2020 | 24330 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2437 | 0.060 |
Why?
|
| Cerebral Hemorrhage, Traumatic | 1 | 2005 | 20 | 0.060 |
Why?
|
| Cytochromes c | 1 | 2006 | 173 | 0.060 |
Why?
|
| Hyperglycemia | 2 | 2018 | 1389 | 0.060 |
Why?
|
| Neurotoxins | 1 | 2006 | 241 | 0.060 |
Why?
|
| Swine | 1 | 2015 | 5998 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 615 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2008 | 1266 | 0.060 |
Why?
|
| Respiratory Function Tests | 1 | 2010 | 1695 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 8055 | 0.060 |
Why?
|
| Arachidonic Acid | 1 | 2006 | 429 | 0.060 |
Why?
|
| Visual Perception | 1 | 2013 | 1407 | 0.060 |
Why?
|
| Anesthesia, Inhalation | 2 | 2004 | 220 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2008 | 691 | 0.060 |
Why?
|
| Mitochondrial Membranes | 1 | 2006 | 185 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2020 | 8095 | 0.060 |
Why?
|
| HELLP Syndrome | 1 | 2004 | 40 | 0.060 |
Why?
|
| Education, Continuing | 1 | 2005 | 115 | 0.060 |
Why?
|
| Catheters | 2 | 2019 | 427 | 0.060 |
Why?
|
| Ointments | 1 | 2004 | 58 | 0.060 |
Why?
|
| Nitrates | 1 | 2005 | 260 | 0.060 |
Why?
|
| Motor Neuron Disease | 1 | 2004 | 98 | 0.060 |
Why?
|
| Preoperative Care | 2 | 2017 | 2258 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2006 | 731 | 0.060 |
Why?
|
| Blood Glucose | 2 | 2018 | 6434 | 0.060 |
Why?
|
| Anesthetics, Intravenous | 2 | 2004 | 397 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 3447 | 0.060 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 2252 | 0.060 |
Why?
|
| Androstanols | 1 | 2003 | 47 | 0.060 |
Why?
|
| Trigeminal Ganglion | 1 | 2004 | 186 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7460 | 0.060 |
Why?
|
| Gastritis | 1 | 2005 | 199 | 0.050 |
Why?
|
| Moscow | 1 | 2003 | 6 | 0.050 |
Why?
|
| Body Weight | 1 | 2014 | 4628 | 0.050 |
Why?
|
| Heart Septum | 1 | 2004 | 304 | 0.050 |
Why?
|
| Colony Count, Microbial | 1 | 2004 | 328 | 0.050 |
Why?
|
| Punctures | 1 | 2004 | 372 | 0.050 |
Why?
|
| Intracranial Hypertension | 1 | 2005 | 193 | 0.050 |
Why?
|
| Nitriles | 1 | 2008 | 990 | 0.050 |
Why?
|
| Fascia | 1 | 2023 | 143 | 0.050 |
Why?
|
| Accidents, Occupational | 1 | 2004 | 251 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2019 | 54950 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2005 | 2862 | 0.050 |
Why?
|
| Aging | 3 | 2014 | 8765 | 0.050 |
Why?
|
| Helicobacter pylori | 1 | 2005 | 380 | 0.050 |
Why?
|
| Cytosol | 1 | 2005 | 886 | 0.050 |
Why?
|
| Uremia | 1 | 2003 | 202 | 0.050 |
Why?
|
| Liver Function Tests | 1 | 2003 | 526 | 0.050 |
Why?
|
| Spinal Puncture | 1 | 2004 | 286 | 0.050 |
Why?
|
| Helicobacter Infections | 1 | 2005 | 390 | 0.050 |
Why?
|
| Hernia, Inguinal | 1 | 2004 | 225 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 12252 | 0.050 |
Why?
|
| Drug Therapy, Combination | 3 | 2017 | 6320 | 0.050 |
Why?
|
| Cross-Over Studies | 2 | 2005 | 2108 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2002 | 175 | 0.050 |
Why?
|
| Forearm | 1 | 2004 | 428 | 0.050 |
Why?
|
| Area Under Curve | 1 | 2005 | 1645 | 0.050 |
Why?
|
| Toluidines | 1 | 2001 | 21 | 0.050 |
Why?
|
| Kidney Function Tests | 1 | 2003 | 684 | 0.050 |
Why?
|
| Urologic Surgical Procedures | 1 | 2004 | 299 | 0.050 |
Why?
|
| Propofol | 2 | 2004 | 608 | 0.050 |
Why?
|
| Phenotype | 3 | 2008 | 16735 | 0.040 |
Why?
|
| Craniotomy | 1 | 2005 | 747 | 0.040 |
Why?
|
| Inhalation Exposure | 1 | 2003 | 431 | 0.040 |
Why?
|
| Polytetrafluoroethylene | 1 | 2021 | 245 | 0.040 |
Why?
|
| Postoperative Care | 2 | 2017 | 1481 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 18366 | 0.040 |
Why?
|
| Fluid Therapy | 1 | 2004 | 587 | 0.040 |
Why?
|
| Demography | 1 | 2005 | 1643 | 0.040 |
Why?
|
| Neutrophils | 1 | 2013 | 3785 | 0.040 |
Why?
|
| Rhinoplasty | 1 | 2003 | 241 | 0.040 |
Why?
|
| Veins | 1 | 2004 | 769 | 0.040 |
Why?
|
| Vascular Grafting | 1 | 2021 | 163 | 0.040 |
Why?
|
| Nitric Oxide | 3 | 2005 | 2149 | 0.040 |
Why?
|
| Iceland | 1 | 2019 | 183 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 1494 | 0.040 |
Why?
|
| Hospital Administration | 1 | 2003 | 353 | 0.040 |
Why?
|
| Infusions, Subcutaneous | 1 | 2019 | 43 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2010 | 2957 | 0.040 |
Why?
|
| Functional Laterality | 1 | 2005 | 2269 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2002 | 706 | 0.040 |
Why?
|
| Young Adult | 6 | 2019 | 60110 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2004 | 2695 | 0.040 |
Why?
|
| Hand | 1 | 2004 | 913 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2004 | 42684 | 0.040 |
Why?
|
| Vascular Patency | 1 | 2021 | 917 | 0.040 |
Why?
|
| Hydrogels | 1 | 2004 | 745 | 0.040 |
Why?
|
| Observer Variation | 1 | 2004 | 2623 | 0.040 |
Why?
|
| Peritoneum | 1 | 2019 | 231 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 17174 | 0.030 |
Why?
|
| Syndrome | 1 | 2003 | 3274 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2012 | 12809 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2008 | 8317 | 0.030 |
Why?
|
| Infusions, Intralesional | 1 | 2016 | 3 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2010 | 26394 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2012 | 10486 | 0.030 |
Why?
|
| Drug Dosage Calculations | 1 | 2016 | 117 | 0.030 |
Why?
|
| Tibial Nerve | 1 | 2016 | 55 | 0.030 |
Why?
|
| Peroneal Nerve | 1 | 2016 | 80 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2001 | 773 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 8664 | 0.030 |
Why?
|
| Polymers | 1 | 2003 | 1632 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2004 | 1430 | 0.030 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2016 | 139 | 0.030 |
Why?
|
| Environmental Monitoring | 1 | 2002 | 1466 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 2011 | 3250 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 1493 | 0.030 |
Why?
|
| Anaphylaxis | 1 | 2003 | 758 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2005 | 3138 | 0.030 |
Why?
|
| Shock, Septic | 1 | 2002 | 774 | 0.030 |
Why?
|
| Knee Joint | 1 | 2024 | 1685 | 0.030 |
Why?
|
| Laparotomy | 1 | 2017 | 459 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2016 | 443 | 0.030 |
Why?
|
| Sensory Thresholds | 1 | 2016 | 377 | 0.030 |
Why?
|
| Pain Perception | 1 | 2016 | 198 | 0.030 |
Why?
|
| Ion Channels | 1 | 2019 | 1044 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2016 | 704 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2005 | 1483 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2008 | 2931 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2004 | 1473 | 0.030 |
Why?
|
| Models, Biological | 3 | 2008 | 9499 | 0.030 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2017 | 350 | 0.030 |
Why?
|
| Carcinoma | 1 | 2004 | 2340 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2019 | 1177 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2004 | 1941 | 0.030 |
Why?
|
| Evoked Potentials, Motor | 1 | 2016 | 465 | 0.030 |
Why?
|
| Mitochondria | 1 | 2006 | 3683 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2004 | 2110 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2004 | 2724 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 1830 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 2021 | 1515 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2008 | 4064 | 0.030 |
Why?
|
| United States | 1 | 2020 | 73180 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2016 | 683 | 0.020 |
Why?
|
| Patient Preference | 1 | 2019 | 947 | 0.020 |
Why?
|
| Cell Line | 2 | 2005 | 15603 | 0.020 |
Why?
|
| Morphine | 1 | 2016 | 658 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2013 | 612 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1796 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2005 | 3591 | 0.020 |
Why?
|
| Acute Disease | 2 | 2017 | 7245 | 0.020 |
Why?
|
| Superoxides | 1 | 2013 | 389 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2018 | 895 | 0.020 |
Why?
|
| Solubility | 1 | 2013 | 1087 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 26384 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2015 | 1445 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2013 | 966 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15955 | 0.020 |
Why?
|
| Volatilization | 1 | 2008 | 76 | 0.020 |
Why?
|
| Oocytes | 1 | 2013 | 1172 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2015 | 2003 | 0.020 |
Why?
|
| Femoral Nerve | 1 | 2008 | 42 | 0.020 |
Why?
|
| Doxepin | 1 | 2007 | 16 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 3056 | 0.020 |
Why?
|
| Imipramine | 1 | 2007 | 98 | 0.020 |
Why?
|
| Oximes | 1 | 2008 | 303 | 0.020 |
Why?
|
| Xerostomia | 1 | 2007 | 94 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2004 | 5443 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2003 | 4711 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 3554 | 0.020 |
Why?
|
| Equipment Design | 2 | 2004 | 3529 | 0.020 |
Why?
|
| Sodium Channel Blockers | 1 | 2007 | 173 | 0.020 |
Why?
|
| Hospitals | 1 | 2019 | 3903 | 0.020 |
Why?
|
| Hydrogen Cyanide | 1 | 2005 | 4 | 0.020 |
Why?
|
| Proprioception | 1 | 2007 | 134 | 0.020 |
Why?
|
| Research Design | 2 | 2015 | 6213 | 0.020 |
Why?
|
| Axotomy | 1 | 2005 | 71 | 0.020 |
Why?
|
| Bradycardia | 1 | 2007 | 305 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2019 | 22294 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2015 | 2990 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 39394 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 1379 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2007 | 321 | 0.010 |
Why?
|
| Ligation | 1 | 2005 | 446 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2005 | 240 | 0.010 |
Why?
|
| Capsaicin | 1 | 2005 | 235 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2005 | 425 | 0.010 |
Why?
|
| Potassium | 1 | 2008 | 1319 | 0.010 |
Why?
|
| Antidotes | 1 | 2005 | 138 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2005 | 20776 | 0.010 |
Why?
|
| Random Allocation | 1 | 2008 | 2396 | 0.010 |
Why?
|
| Recovery Room | 1 | 2003 | 34 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2004 | 5956 | 0.010 |
Why?
|
| Dogs | 1 | 2008 | 3845 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2008 | 864 | 0.010 |
Why?
|
| Air | 1 | 2003 | 187 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 3489 | 0.010 |
Why?
|
| Sleep Stages | 1 | 2007 | 706 | 0.010 |
Why?
|
| Ventilator Weaning | 1 | 2004 | 170 | 0.010 |
Why?
|
| Biotransformation | 1 | 2003 | 166 | 0.010 |
Why?
|
| Operating Room Nursing | 1 | 2002 | 25 | 0.010 |
Why?
|
| Thoracic Injuries | 1 | 2005 | 288 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2007 | 795 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 4077 | 0.010 |
Why?
|
| Elasticity | 1 | 2004 | 657 | 0.010 |
Why?
|
| Glutathione | 1 | 2005 | 589 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18454 | 0.010 |
Why?
|
| Length of Stay | 1 | 2015 | 6525 | 0.010 |
Why?
|
| Postanesthesia Nursing | 1 | 2001 | 10 | 0.010 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2001 | 64 | 0.010 |
Why?
|
| Gastrointestinal Tract | 1 | 2007 | 839 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 1169 | 0.010 |
Why?
|
| Lung Injury | 1 | 2005 | 433 | 0.010 |
Why?
|
| Risk Factors | 2 | 2007 | 74971 | 0.010 |
Why?
|
| Tracheostomy | 1 | 2004 | 430 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2004 | 947 | 0.010 |
Why?
|
| Indoles | 1 | 2008 | 1836 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13677 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 20244 | 0.010 |
Why?
|
| Telephone | 1 | 2003 | 630 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2004 | 1836 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 1667 | 0.010 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2004 | 580 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2015 | 6740 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 2004 | 975 | 0.010 |
Why?
|
| Adolescent | 2 | 2019 | 89247 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 9081 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 9442 | 0.010 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2001 | 326 | 0.010 |
Why?
|
| Medical Staff, Hospital | 1 | 2002 | 603 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 36861 | 0.010 |
Why?
|
| Isoflurane | 1 | 2001 | 384 | 0.010 |
Why?
|
| Positive-Pressure Respiration | 1 | 2002 | 713 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3814 | 0.010 |
Why?
|
| Accidental Falls | 1 | 2005 | 1080 | 0.010 |
Why?
|
| Motor Activity | 1 | 2007 | 2722 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2002 | 1560 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 3659 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2004 | 1241 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 4478 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 4941 | 0.010 |
Why?
|
| Reoperation | 1 | 2004 | 4342 | 0.010 |
Why?
|
| Heart | 1 | 2007 | 4448 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2005 | 2058 | 0.010 |
Why?
|
| Child | 1 | 2021 | 80969 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2003 | 5544 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2005 | 4850 | 0.010 |
Why?
|
| Curriculum | 1 | 2003 | 3782 | 0.010 |
Why?
|
| Lung | 1 | 2005 | 10097 | 0.000 |
Why?
|
| Algorithms | 1 | 2007 | 14199 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 15471 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 15662 | 0.000 |
Why?
|
| Infant | 1 | 2002 | 36541 | 0.000 |
Why?
|
| Brain | 1 | 2005 | 27476 | 0.000 |
Why?
|